Skip to main content
Top
Published in: Clinical & Experimental Metastasis 1/2011

Open Access 01-01-2011 | Research Paper

Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis

Authors: Toshihiro Seike, Kyota Fujita, Yukiko Yamakawa, Mizuho A. Kido, Soichi Takiguchi, Norihiro Teramoto, Haruo Iguchi, Mami Noda

Published in: Clinical & Experimental Metastasis | Issue 1/2011

Login to get access

Abstract

The incidence of brain metastasis is increasing, however, little is known about molecular mechanism responsible for lung cancer-derived brain metastasis and their development in the brain. In the present study, brain pathology was examined in an experimental model system of brain metastasis as well as in human brain with lung cancer metastasis. In an experimental model, after 3–6 weeks of intracardiac inoculation of human lung cancer-derived (HARA-B) cells in nude mice, wide range of brain metastases were observed. The brain sections showed significant increase in glial fibrillary acidic protein (GFAP)-positive astrocytes around metastatic lesions. To elucidate the role of astrocytes in lung cancer proliferation, the interaction between primary cultured mouse astrocytes and HARA-B cells was analyzed in vitro. Co-cultures and insert-cultures demonstrated that astrocytes were activated by tumor cell-oriented factors; macrophage migration inhibitory factor (MIF), interleukin-8 (IL-8) and plasminogen activator inhibitor-1 (PAI-1). Activated astrocytes produced interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and interleukin-1 β (IL-1β), which in turn promoted tumor cell proliferation. Semi-quantitative immunocytochemistry showed that increased expression of receptors for IL-6 and its subunits gp130 on HARA-B cells. Receptors for TNF-α and IL-1β were also detected on HARA-B cells but down-regulated after co-culture with astrocytes. Insert-culture with astrocytes also stimulated the proliferation of other lung cancer-derived cell lines (PC-9, QG56, and EBC-1). These results suggest that tumor cells and astrocytes stimulate each other and these mutual relationships may be important to understand how lung cancer cells metastasize and develop in the brain.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schouten LJ, Rutten J, Huveneers HA, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698–2705CrossRefPubMed Schouten LJ, Rutten J, Huveneers HA, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698–2705CrossRefPubMed
2.
go back to reference Fidler IJ, Yano S, Zhang RD et al (2002) The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3:53–57CrossRefPubMed Fidler IJ, Yano S, Zhang RD et al (2002) The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3:53–57CrossRefPubMed
3.
go back to reference Aloisi F, Ria F, Adorini L (2000) Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today 21:141–147CrossRefPubMed Aloisi F, Ria F, Adorini L (2000) Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today 21:141–147CrossRefPubMed
4.
5.
go back to reference Fitzgerald DP, Palmieri D, Hua E et al (2008) Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization. Clin Exp Metastasis 25(7):799–810CrossRefPubMed Fitzgerald DP, Palmieri D, Hua E et al (2008) Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization. Clin Exp Metastasis 25(7):799–810CrossRefPubMed
6.
go back to reference Miller RH, Ffrench-Constant C, Raff MC (1989) The macroglial cells of the rat optic nerve. Annu Rev Neurosci 12:517–534CrossRefPubMed Miller RH, Ffrench-Constant C, Raff MC (1989) The macroglial cells of the rat optic nerve. Annu Rev Neurosci 12:517–534CrossRefPubMed
7.
go back to reference Aloisi F, Care A, Borsellino G et al (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol 149:2358–2366PubMed Aloisi F, Care A, Borsellino G et al (1992) Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J Immunol 149:2358–2366PubMed
8.
go back to reference Hertz L, McFarlin DE, Waksman BH (1990) Astrocytes: auxiliary cells for immune responses in the central nervous system? Immunol Today 11:265–268CrossRefPubMed Hertz L, McFarlin DE, Waksman BH (1990) Astrocytes: auxiliary cells for immune responses in the central nervous system? Immunol Today 11:265–268CrossRefPubMed
9.
go back to reference Lee SC, Liu W, Dickson DW et al (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150:2659–2667PubMed Lee SC, Liu W, Dickson DW et al (1993) Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150:2659–2667PubMed
10.
go back to reference Wang FW, Jia DY, Du ZH et al (2009) Roles of activated astrocytes in bone marrow stromal cell proliferation and differentiation. Neuroscience 160(2):319–329CrossRefPubMed Wang FW, Jia DY, Du ZH et al (2009) Roles of activated astrocytes in bone marrow stromal cell proliferation and differentiation. Neuroscience 160(2):319–329CrossRefPubMed
11.
go back to reference Sierra A, Price JE, Garcia-Ramirez M et al (1997) Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. Lab Invest 77:357–368PubMed Sierra A, Price JE, Garcia-Ramirez M et al (1997) Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. Lab Invest 77:357–368PubMed
12.
go back to reference Iguchi H, Tanaka S, Ozawa Y et al (1996) An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 56:4040–4043PubMed Iguchi H, Tanaka S, Ozawa Y et al (1996) An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 56:4040–4043PubMed
13.
go back to reference Lyons S, Kettenmann K (1998) Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro. J Cereb Blood Flow Metab 18:521–530CrossRefPubMed Lyons S, Kettenmann K (1998) Oligodendrocytes and microglia are selectively vulnerable to combined hypoxia and hypoglycemia injury in vitro. J Cereb Blood Flow Metab 18:521–530CrossRefPubMed
14.
go back to reference Zhang M, Olsson Y (1995) Reactions of astrocytes and microglial cells around hematogenous metastases of the human brain. Expression of endothelin-like immunoreactivity in reactive astrocytes and activation of microglial cells. J Neurol Sci 134:26–32CrossRefPubMed Zhang M, Olsson Y (1995) Reactions of astrocytes and microglial cells around hematogenous metastases of the human brain. Expression of endothelin-like immunoreactivity in reactive astrocytes and activation of microglial cells. J Neurol Sci 134:26–32CrossRefPubMed
15.
go back to reference Giavazzi R, Garofalo A, Bani MR et al (1990) Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 50:4771–4775PubMed Giavazzi R, Garofalo A, Bani MR et al (1990) Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 50:4771–4775PubMed
16.
go back to reference Vidal-Vanaclocha F, Amezaga C, Asumendi A et al (1994) Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 54:2667–2672PubMed Vidal-Vanaclocha F, Amezaga C, Asumendi A et al (1994) Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res 54:2667–2672PubMed
17.
go back to reference Vidal-Vanaclocha F, Alvarez A, Asumendi A (1996) Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst 88:198–205CrossRefPubMed Vidal-Vanaclocha F, Alvarez A, Asumendi A (1996) Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst 88:198–205CrossRefPubMed
18.
go back to reference Marchetti D, Denkins Y, Reiland J et al (2003) Brain-metastatic melanoma: a neurotrophic perspective. Pathol Oncol Res 9(3):147–158CrossRefPubMed Marchetti D, Denkins Y, Reiland J et al (2003) Brain-metastatic melanoma: a neurotrophic perspective. Pathol Oncol Res 9(3):147–158CrossRefPubMed
19.
go back to reference Denkins Y, Reiland J, Roy M et al (2004) Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol 6(2):154–165CrossRefPubMed Denkins Y, Reiland J, Roy M et al (2004) Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol 6(2):154–165CrossRefPubMed
20.
go back to reference Yoshida S, Takahashi H (2009) Expression of extracellular matrix molecules in brain metastasis. J Surg Oncol 100(1):65–68CrossRefPubMed Yoshida S, Takahashi H (2009) Expression of extracellular matrix molecules in brain metastasis. J Surg Oncol 100(1):65–68CrossRefPubMed
21.
go back to reference Iguchi H, Onuma E, Sato K et al (2001) Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen. Int J Cancer 94(1):24–27CrossRefPubMed Iguchi H, Onuma E, Sato K et al (2001) Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen. Int J Cancer 94(1):24–27CrossRefPubMed
22.
go back to reference Funk JL, Trout CR, Wei H et al (2001) Parathyroid hormone-related protein (PTHrP) induction in reactive astrocytes following brain injury: a possible mediator of CNS inflammation. Brain Res 915(2):195–209CrossRefPubMed Funk JL, Trout CR, Wei H et al (2001) Parathyroid hormone-related protein (PTHrP) induction in reactive astrocytes following brain injury: a possible mediator of CNS inflammation. Brain Res 915(2):195–209CrossRefPubMed
23.
go back to reference Bauer M, Gräbsch C, Gminski R et al (2010) Cement-related particles interact with proinflammatory IL-8 chemokine from human primary oropharyngeal mucosa cells and human epithelial lung cancer cell line A549. Environ Toxicol. doi:10.1002/tox.20643 Bauer M, Gräbsch C, Gminski R et al (2010) Cement-related particles interact with proinflammatory IL-8 chemokine from human primary oropharyngeal mucosa cells and human epithelial lung cancer cell line A549. Environ Toxicol. doi:10.​1002/​tox.​20643
24.
go back to reference Yang S, Su J, Cao J et al (2009) Establishment of a novel Chinese human lung adenocarcinoma cell line CPA-Yang1 which produces highly bone metastases in immunodeficient mice. Zhongguo Fei Ai Za Zhi 12(7):753–759PubMed Yang S, Su J, Cao J et al (2009) Establishment of a novel Chinese human lung adenocarcinoma cell line CPA-Yang1 which produces highly bone metastases in immunodeficient mice. Zhongguo Fei Ai Za Zhi 12(7):753–759PubMed
25.
go back to reference Liu Z, Xu S, Xiao N et al (2010) Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 13(8):795–802PubMed Liu Z, Xu S, Xiao N et al (2010) Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 13(8):795–802PubMed
26.
go back to reference Crohns M, Saarelainen S, Laine S et al (2010) Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy—association of interleukin-8 and VEGF with survival. Cytokine 50(1):30–36CrossRefPubMed Crohns M, Saarelainen S, Laine S et al (2010) Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy—association of interleukin-8 and VEGF with survival. Cytokine 50(1):30–36CrossRefPubMed
27.
go back to reference Khan N, Cromer CJ, Campa M, Patz EF Jr (2004) Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 101(2):379–384CrossRefPubMed Khan N, Cromer CJ, Campa M, Patz EF Jr (2004) Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 101(2):379–384CrossRefPubMed
28.
go back to reference McClelland M, Zhao L, Carskadon S, Arenberg D (2009) Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol 174(2):638–646CrossRefPubMed McClelland M, Zhao L, Carskadon S, Arenberg D (2009) Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol 174(2):638–646CrossRefPubMed
29.
go back to reference Liu Q, Yang H, Zhang SF (2010) Expression and significance of MIF and CD147 in non-small cell lung cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 41(1):85–90PubMed Liu Q, Yang H, Zhang SF (2010) Expression and significance of MIF and CD147 in non-small cell lung cancer. Sichuan Da Xue Xue Bao Yi Xue Ban 41(1):85–90PubMed
30.
go back to reference Rendon BE, Roger T, Teneng I et al (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 282(41):29910–29918CrossRefPubMed Rendon BE, Roger T, Teneng I et al (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 282(41):29910–29918CrossRefPubMed
31.
go back to reference Offersen BV, Pfeiffer P, Andreasen P, Overgaard J (2007) Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis. Lung Cancer 56(1):43–50CrossRefPubMed Offersen BV, Pfeiffer P, Andreasen P, Overgaard J (2007) Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis. Lung Cancer 56(1):43–50CrossRefPubMed
32.
go back to reference Ramer R, Rohde A, Merkord J et al (2010) Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells. Pharm Res 27(10):2162–2174CrossRefPubMed Ramer R, Rohde A, Merkord J et al (2010) Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells. Pharm Res 27(10):2162–2174CrossRefPubMed
33.
go back to reference Chorostowska-Wynimko J, Kedzior M, Struniawski R et al (2010) Cell phenotype determines PAI-1 antiproliferative effect—suppressed proliferation of the lung cancer but not prostate cancer cells. Pneumonol Alergol Pol 78(4):279–283PubMed Chorostowska-Wynimko J, Kedzior M, Struniawski R et al (2010) Cell phenotype determines PAI-1 antiproliferative effect—suppressed proliferation of the lung cancer but not prostate cancer cells. Pneumonol Alergol Pol 78(4):279–283PubMed
34.
go back to reference Di Bernardo MC, Matakidou A, Eisen T, Houlston RS (2009) GELCAPS Consortium. Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis. Lung Cancer 65(2):237–241CrossRefPubMed Di Bernardo MC, Matakidou A, Eisen T, Houlston RS (2009) GELCAPS Consortium. Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis. Lung Cancer 65(2):237–241CrossRefPubMed
35.
go back to reference Shetty S, Shetty P, Idell S et al (2008) Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J Biol Chem 283(28):19570–19580CrossRefPubMed Shetty S, Shetty P, Idell S et al (2008) Regulation of plasminogen activator inhibitor-1 expression by tumor suppressor protein p53. J Biol Chem 283(28):19570–19580CrossRefPubMed
36.
go back to reference van der Poll T, Coyle SM, Kumar A et al (1997) Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor. J Immunol 158(3):1490–1497PubMed van der Poll T, Coyle SM, Kumar A et al (1997) Down-regulation of surface receptors for TNF and IL-1 on circulating monocytes and granulocytes during human endotoxemia: effect of neutralization of endotoxin-induced TNF activity by infusion of a recombinant dimeric TNF receptor. J Immunol 158(3):1490–1497PubMed
37.
go back to reference Mihara M, Ohsugi Y, Kishimoto T (2009) Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody. Biofactors 35(1):47–51CrossRefPubMed Mihara M, Ohsugi Y, Kishimoto T (2009) Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti-interluekin-6 receptor antibody. Biofactors 35(1):47–51CrossRefPubMed
38.
go back to reference He BP, Wang JJ, Zhang X et al (2006) Differential reactions of microglia to brain metastasis of lung cancer. Mol Med 12(7–8):161–170PubMed He BP, Wang JJ, Zhang X et al (2006) Differential reactions of microglia to brain metastasis of lung cancer. Mol Med 12(7–8):161–170PubMed
Metadata
Title
Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis
Authors
Toshihiro Seike
Kyota Fujita
Yukiko Yamakawa
Mizuho A. Kido
Soichi Takiguchi
Norihiro Teramoto
Haruo Iguchi
Mami Noda
Publication date
01-01-2011
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 1/2011
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9354-8

Other articles of this Issue 1/2011

Clinical & Experimental Metastasis 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine